07:00 , Sep 7, 2009 |  BC Week In Review  |  Financial News

Molecular Vision completes venture financing

Molecular Vision Ltd., London, U.K.   Business: Diagnostic, Microflu-idics   Date completed: 9/1/09   Type: Venture financing   Raised: £2 million ($3.3 million)   Investors: Imperial Innovations Group; Acrongenomics   ...
07:00 , Aug 25, 2008 |  BC Week In Review  |  Company News

Acrongenomics, Molecular Vision deal

Acrongenomics returned exclusive rights to develop and commercialize Molecular Vision’s IP covering BioLED technology. In exchange, Acrongenomics will receive royalties on products that use the IP. Acrongenomics also received equity in Molecular Vision, increasing its...
07:00 , Apr 14, 2008 |  BC Week In Review  |  Company News

Acrongenomics, Molecular Vision deal

Molecular Vision terminated its previously announced acquisition by Acrongenomics. Molecular Vision said Acrongenomics did not complete on the agreed-upon terms and timetable. Acrongenomics retains its 10.9% stake in Molecular Vision (see BioCentury, Nov. 19, 2007)....
08:00 , Nov 19, 2007 |  BC Week In Review  |  Company News

Acrongenomics, Molecular Vision deal

AGNM signed a letter of intent to acquire point-of-care diagnostic company Molecular Vision. Financial terms were not disclosed. The companies partnered in May 2006 to develop Molecular Vision's BioLED technology, which uses organic light emitters...
07:00 , Jul 11, 2005 |  BC Week In Review  |  Company News

Acrongenomics sales and marketing update

Acrongenomics launched its Nano-JETA real-time PCR kits for nucleic acid quantification. Acrongenomics Inc., Athens, Greece   Business: Supply/Service   ...
07:00 , Jun 7, 2004 |  BC Week In Review  |  Company News

Acrongenomics board of directors update

Acrongenomics Inc. (AGNM), Calgary, Alberta   Business: Diagnostic   Appointed: Teni Boulikas, chairman and CEO of Regulon   ...